Synageva BioPharma Corp (GEVA.OQ)

GEVA.OQ on NASDAQ Stock Exchange Global Select Market

64.65USD
12:56pm EDT
Price Change (% chg)

$0.04 (+0.06%)
Prev Close
$64.61
Open
$65.11
Day's High
$65.11
Day's Low
$63.63
Volume
52,727
Avg. Vol
95,260
52-wk High
$119.04
52-wk Low
$44.63

GEVA.OQ

Chart for GEVA.OQ

About

Synageva BioPharma Corp. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapeutic products. It has several protein therapeutics in development, including two enzyme replacement therapies for lysosomal storage disorders and two programs for life-threa... (more)

Overall

Beta: 0.54
Market Cap (Mil.): $2,142.82
Shares Outstanding (Mil.): 33.17
Dividend: --
Yield (%): --

Financials

  GEVA.OQ Industry Sector
P/E (TTM): -- 143.76 33.47
EPS (TTM): -4.70 -- --
ROI: -33.17 -2.42 17.39
ROE: -33.40 -7.11 18.25
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: Pechala's Reports
$15.00
Provider: Pechala's Reports
$25.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks